Taste masked orodispersible tablet of atomoxetine hydrochloride

Latin American Journal of Pharmacy

Volumn 30, Issue 9, 2011, Pages 1785-1791

  Huda, Inderjeet S G ^a   Toshniwal, Sanjay S ^a  

^a Dr V P College of Pharmacy   (India)

Author keywords

Atomoxetine HCl; Ion exchange resin; Kyron T 134; Orodispersible tablet

Indexed keywords

ATOMOXETINE; CROSCARMELLOSE SODIUM; CROSPOVIDONE; HYDROCHLORIC ACID; ION EXCHANGE RESIN; STARCH GLYCOLATE SODIUM;

ARTICLE; BATCH PROCESS; COMPLEX FORMATION; CONTROLLED STUDY; DISPERSION; DRUG CONTENT; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; ORODISPERSIBLE TABLET; PH; PHYSICAL PARAMETERS; TABLET; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TASTE;

EID: 83455264030     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Seager, H. (1998) J. Pharm. Pharmacol. 50: 375-82.
2. Sastry, S.V., J.R. Nyshadham & J.A. Fix (2000) Pharm. Sci. Technol. Today 3: 138-45.
3. Mallet, L. (1996) J. Am. Pharm. Assoc. 36: 628-35.
4. Habib, W., R. Khankari and, J. Hontz (2000) Ther. Drug Carrier Syst. 17: 61-72.
5. Chang, R., X. Guo, B. Burnside & R. Couch (2000) Pharm Tech. 24: 52-8.
6. Laboratoire L.Lefon (1985) Maisons-Alfort, France, European Patent 0159 237.
7. Green, R. & P. Kearney (1999) US Patent 5 976 577.
8. Bruna, E., G. Cousin & E. Gendrot (1995) US Patent 5 464 632.
9. Dobetti, L. (2001) Pharm. Technol. Drug Deliv. Suppl. ¿Vol?: 44-50.
10. Morita, Y., Y. Tsushima, R. Termoz, J. Ajioka & K. Takayama (2002) Chem. Pharm. Bull. 50: 1181-6.
11. Bi, Y., H. Sunada, Y. Yonezawa, K. Dayo, A. Otsuka & K. Iida (1996) Chem. Pharm. Bull. 44: 2121-7.
12. Watanabe, Y., Y. Yamamoti, M. Fujii, M. Kondoh & Y. Shibata (2004) Chem. Pharm. Bull. 52: 1394-5.
13. Eli Lilly and Company (1995) Indianapolis, IN. US Patent 5 658 590.
14. Borodkin, S. & D.P. Sundberg (1971) J. Pharm. Sci. 60: 1523-7.
15. Swarbrick, J. & J.C. Boylan, eds. (1993) "Encyclopedia of Pharmaceutical Technology" Marcel Dekker, New York, pp. 203-16.
16. Notari, R.E. (1987) "Biopharmaceutics and Clinical Pharmacokinetics" 4th ed. Marcel Dekker, New York.
17. Borodkin, S. & M.H. Yunker (1970) J. Pharm. Sci. 59: 481-6.
18. Bhise, K., S. Shaikh & D. Bora (2008) AAPS PharmSciTech. 9: 557-62.
19. Agrawal, R., R. Mittal & A. Singh (2000) Drug Dev. Ind. Pahrm. 26: 773-6.
20. United States Pharmacopoeia 24 & National Formulary 19 (2000) The Official Compendia of Standards. Asian ed. Rockville, MD, pp. 1913-4.
21. Martin, A. (2001) "Physical Pharmacy" 5th ed. Lippincott Williams & Wilkins Philadelphia, PA.
22. Wells, J. (2002) "Pharmaceutical preformulation: The physiochemical properties of drug substances", in "Pharmaceutics the science of dosage form design" (M. E. Aulton, ed.). London, Churchill Livingstone.